| Sources | Names Used |
|---|---|
| CTRPv2 | triazolothiadiazine |
| PharmacoGx | triazolothiadiazine |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD63 | CTRPv2 | pan-cancer | AAC | -0.26 | 2e-12 |
| mRNA | RHBDF1 | CTRPv2 | pan-cancer | AAC | -0.26 | 3e-13 |
| mRNA | FAM114A1 | CTRPv2 | pan-cancer | AAC | -0.24 | 3e-11 |
| mRNA | BCL2L1 | CTRPv2 | pan-cancer | AAC | -0.24 | 4e-14 |
| mRNA | RP11-426L16.10 | CTRPv2 | pan-cancer | AAC | -0.23 | 8e-11 |
| mRNA | GRAMD3 | CTRPv2 | pan-cancer | AAC | -0.23 | 8e-13 |
| mRNA | MYOF | CTRPv2 | pan-cancer | AAC | -0.22 | 9e-11 |
| mRNA | RHOC | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-10 |
| mRNA | KRT18 | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-10 |
| mRNA | GIPC1 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-09 |
